SMS Pharmaceuticals jumped 5.27% to Rs 288.45 after the company's associate company, VKT Pharma, has received approval from the US Food and Drug Administration (USFDA) for its reformulated Ranitidine ...
Flamengo and Palmeiras took the field this Tuesday (25), with their "minds" on the Conmebol Libertadores final in Lima, Peru, ...
Evaluation of Concentrations and Dispersion of Heavy Metals in Soils Surrounding Artisanal and Small-Scale Gold Mining in ...
L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition, offering a balance of ...
South Africa’s successful hosting of the G20 was not merely a diplomatic accomplishment, it was a national stress test. And we passed it with force. Over the past days, as our country welcomed 45 ...
Inflammasome Therapeutics, a private, clinical-stage biotech company developing novel, first-in-class, dual inflammasome inhibitors for prevalent ophthalmic and neurodegenerative diseases, announced ...
JackRabbit has already made a name for itself with quirky, ultra-lightweight microbikes like the JackRabbit OG and XG series. Dubbed “micro e-bikes”, despite their lack of bicycle pedals, they tend to ...
FDA approves dosing in Sarepta's ENDEAVOR Cohort 8 to test sirolimus with Elevidys in non-ambulant Duchenne patients, ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...
Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically ...